Given the dependence of prostate cancer on androgens and the prior report of LRP2 polymorphisms with prostate cancer aggressiveness (24), we examined megalin protein and LRP2 gene expression in patients with prostate cancer. This evidence concerns the gene LRP2 and prostate cancer.